Long-term management of the kidney transplant recipient

Blood Purification

Volumn 33, Issue 1-3, 2012, Pages 205-211

  Schaefer, Heidi M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allograft function; Anemia; Diabetes; Dyslipidemia; Hypertension; Infection; Kidney transplantation; Malignancy

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN RECEPTOR ANTAGONIST; ATOVAQUONE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; COTRIMOXAZOLE; DAPSONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENTAMIDINE; RAPAMYCIN; RECOMBINANT ERYTHROPOIETIN; STEROID; TACROLIMUS;

ALLOGRAFT; ANEMIA; BONE METABOLISM; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DRUG INDICATION; DYSLIPIDEMIA; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LIFESTYLE MODIFICATION; LONG TERM CARE; OBESITY; PATIENT CARE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK FACTOR; TOBACCO DEPENDENCE;

CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; GRAFT REJECTION; HUMANS; HYPERTENSION; INFECTION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEOPLASMS;

EID: 84856063029     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000334158     Document Type: Conference Paper

References (41)

1. Wolfe RA, Roys EC, Merion RM: Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant 2010;10:961-972.
2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. NEngl JMed l999;34l: 1725-1730.
3. Kasiske BL: Ischemic heart disease after renal transplantation. Kidney Int 2002;6l: 356-369.
4. Ojo AO: Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006;82:603-611.
5. Campistol JM, Romero R, Paul J, Gutierrez-Dalmau A: Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Nephrol Dial Transplant 2004;l9(suppl 3):62-66.
6. Kasiske BL, Anjum S, Shah R, Skogen J, Kan-daswamy C, Danielson B, et al: Hypertension after kidney transplantation. Am J Kidney Dis 2004;43:1071-1081.
7. Kobashigawa JA, Kasiske BL: Hyperlipid-emia in solid organ transplantation. Transplantation 1997;63:331-338.
8. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
9. Jardine AG, Holdaas H, Fellstrom B, Cole E, Nyberg G, Gronhagen-Riska C, et al: Fluva-statin prevents cardiac death and myocardi-al infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am J Transplant 2004;4:988-995.
10. Kasiske B, Cosio FG, Beto J, Bolton K, Cha-vers BM, Grimm R Jr, et al: Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 2004;4(suppl 7):1-53.
11. Puthenparumpil JJ, Keough-Ryan T, Kiberd M, Lawen J, Kiberd BA: Treatment of hyper-cholesterolemia with ezetimibe in the kidney transplant population. Transplant Proc 2005;37:1033-1035.
12. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3:178-185.
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 200;26(suppl l):S5-S2O.
14. Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, et al: Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005;19:291-298.
15. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, et al: Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003;3:835-845.
16. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, et al: Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;ll(suppl l5):Sl-S86.
17. Mix TC, Kazmi W, Khan S, Ruthazer R, Rohrer R, Pereira BJ, et al: Anemia: a continuing problem following kidney transplantation. Am J Transplant 2000;3:1426-1433.
18. Rigatto C: Anemia, renal transplantation, and the anemia paradox. Semin Nephrol 2006;26:307-312.
19. IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis 211l;37(1 suppl l):Sl82-S238.
20. Bia M: Evaluation and management of bone disease and fractures post transplant. Transplant Rev (Orlando) 2008;22:52-61.
21. Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B: Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation l999;67: 18-1222.
22. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD: Rapid loss of vertebral mineral density after renal transplantation. NEnglJMed l99l;325:544-550.
23. Palmer SC, Strippoli GF, McGregor DO: Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 2005;45:638-649.
24. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P, et al: Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pami-dronate. J Am Soc Nephrol 2003; 14:2669-2676.
25. Karthikeyan V Karpinski J, Nair RC, Knoll G: The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 2004;4:262-269.
26. Halloran PF, Melk A, Barth C: Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999;10:167-181.
27. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF: Blockade of the renin-angio-tensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 2004; 19:2852-2857.
28. Lin J, Valeri AM, Markowitz GS, DAgati VD, Cohen DJ, Radhakrishnan J: Angioten-sin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 2002;73:783-788.
29. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 2003;349:2326-2333.
30. Mulay AV, Hussain N, Fergusson D, Knoll GA: Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant 2005;5:1748-1756.
31. Mulay AV, Cockfield S, Stryker R, Fergusson D, Knoll GA: Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence. Transplantation 2006;82:1153-1162.
32. Chadban S: Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001; 12: 394-402.
33. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med 2007;357: 2601-2614.
34. Humar A, Lebranchu Y, Vincenti F, Blum-berg EA, Punch JD, Limaye AP, et al: The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant 2010;10:1228-1237.
35. Kotton CN, Ryan ET, Fishman JA: Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 2005;5:8-14.
36. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:9O5-913.
37. Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M: Malignancy in renal transplantation. J Am Soc Nephrol 2004;1582-1588.
38. Mathew T, Kreis H, Friend P: Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18:446-449.
39. McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, et al: Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005;5:1592-1599.
40. Pirsch JD, Armbrust MJ, Knechtle SJ, DAlessandro AM, Sollinger HW, Heisey DM, et al: Obesity as a risk factor following renal transplantation. Transplantation 1995; 59:631-633.
41. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM: Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 200l;7l: 1752-1757.